The long-awaited final draft of Solvency II has brought the debate over "equivalency" status and, in particular, the status of US insurance regulation centre stage.
The long-awaited final draft of Solvency II has brought the debate over "equivalency" status and, in particular, the status of US insurance regulation centre stage.